GSK plc (GSK)
Official siteHEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE
Market Cap: $101.13B
Last updated: Nov 17, 2026 at 4:25 PM ET
GSK plc (GSK) Stock Chart
GSK has a latest price of $49.23 on Nov 17, 2026, 17.4% below its 52-week high of $59.57. Its price rose 5.2% over the past 12 months. The month-end price fell 1.0% over the 10 years through Oct 2026, a compound annual decline of 0.1%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $59.13 in Feb 2026 and its lowest $29.43 in Sep 2022, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart GSK with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for GSK.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 6.1%, and over 6 months it fell 2.7%. The month-end price rose 38.7% over the 3 years through Oct 2026, a compound annual rate of 11.5%.
| Period | Change |
|---|---|
| 1 month | +0.4% |
| 3 months | -6.1% |
| 6 months | -2.7% |
| 12 months | +5.2% |
| 12 months, with dividends | +9.1% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +38.7% | +11.5% |
| 5 years | -6.4% | -1.3% |
| 10 years | -1.0% | -0.1% |
Price by Year
Its best calendar year was 2025, when the price rose 45.0%, and its weakest was 2022, when it fell 36.3%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $49.51 | +1.0% |
| 2025 | $49.04 | +45.0% |
| 2024 | $33.82 | -8.7% |
| 2023 | $37.06 | +5.5% |
| 2022 | $35.14 | -36.3% |
| 2021 | $55.13 | +19.8% |
| 2020 | $46.00 | -21.7% |
| 2019 | $58.74 | +23.0% |
| 2018 | $47.76 | +7.7% |
| 2017 | $44.34 | -7.9% |
Trading Range
The price is 0.6% above its 50-day average of $48.91 and 4.8% below its 200-day average of $51.72.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $49.23 | |
| 52-week high | $59.57 | -17.4% |
| 52-week low | $44.23 | +11.3% |
| 50-day average | $48.91 | +0.6% |
| 200-day average | $51.72 | -4.8% |
Price Risk
Over 3 years, its largest fall from a peak was 28.5%.
| Measure | Value |
|---|---|
| 1-year beta | 0.28 |
| Largest fall, 1 year | -23.8% |
| Largest fall, 3 years | -28.5% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About GSK
What is GSK's 1-year price change?
GSK's price rose 5.2% over the past 12 months. With dividends included, the 12-month total return was 9.1%.
What is GSK's 5-year price change?
GSK's month-end price fell 6.4% over the 5 years through Oct 2026, a compound annual decline of 1.3%. These figures leave out dividends.
What is GSK's 52-week high and low?
GSK's 52-week high is $59.57 and its 52-week low is $44.23. Its latest price of $49.23 on Nov 17, 2026 is 17.4% below the high.
What is GSK's beta?
GSK's 1-year beta against the S&P 500 is 0.28, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 23.8%.
Is the GSK chart free?
Yes. Advanced Charting for GSK is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
GSK pages: Overview, Dividends, Charting, Financials, Statistics, Valuation, Competitors, Government Contracts